Trial intelligence / Profile preview

Phase 2 randomized study of topical Fibrocaps plus gelatin sponge vs gelatin sponge alone for surgical hemostasis

2010-020202-16Phase 2Completed

Sponsor
ProFibrix
Start
Sep 2010
Modality
Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of tachosil in Not applicable and hepatectomy (2 arms), sponsored by ProFibrix. Primary endpoints: Efficacy of Fibrocaps plus gelatin sponge vs gelatin sponge alone in achieving surgical hemostasis and Safety of Fibrocaps plus gelatin sponge vs gelatin sponge alone. Started Sep 2010; status: completed.

02

Drugs

tachosil
03

Conditions

Not applicablehepatectomy

Beyond the preview

Go deeper on 2010-020202-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020202-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call